InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Chin Mark, Directeur. Director active across 4 companies, notably IMARA Inc.. Aggregated, 12 filings have been recorded. Split: 1 buy · 1 sell. Total volume traded: €11.7m. History available since 16 July 2021. The latest transaction was filed on 8 March 2024 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Chin Mark
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
12 of 12 declarations
About Chin Mark
Chin Mark is Director at Harpoon Therapeutics, Inc. and Iterum Therapeutics plc, and is also listed as a director at IMARA Inc. The 12 filings recorded span from 2021-07-28 to 2024-03-11, with EUR 6772878 of buys and EUR 4914153 of sells in the sampled recent filings, and the most common transaction nature is Attribution.
